(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 23.21% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.81%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.61%.
Glaukos's revenue in 2026 is $551,349,000.On average, 17 Wall Street analysts forecast GKOS's revenue for 2026 to be $36,754,506,826, with the lowest GKOS revenue forecast at $35,053,572,763, and the highest GKOS revenue forecast at $38,151,786,568. On average, 16 Wall Street analysts forecast GKOS's revenue for 2027 to be $46,836,182,649, with the lowest GKOS revenue forecast at $41,183,631,054, and the highest GKOS revenue forecast at $50,796,022,928.
In 2028, GKOS is forecast to generate $61,553,138,728 in revenue, with the lowest revenue forecast at $52,605,027,387 and the highest revenue forecast at $70,421,959,289.